Effects of lisinopril on NMDA receptor subunits 2A and 2B levels in the hippocampus of rats with l-NAME-induced hypertension

References

• Sládková M, Kojsová S, Jendeková L, Pechánová O. Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats. Physiol Res 2007, 56 Suppl 2, S85–S91.
   Google Scholar
• Prugger C, Heuschmann PU, Keil U. [Epidemiology of hypertension in Germany and worldwide]. Herz 2006, 31, 287–293.
   Google Scholar
• Struijs JN, van Genugten ML, Evers SM, Ament AJ, Baan CA, van den Bos GA. Modeling the future burden of stroke in The Netherlands: impact of aging, smoking, and hypertension. Stroke 2005, 36, 1648–1655.
   PubMed Web of Science ®Google Scholar
• Pechanova O, Simko F. Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind. J Hypertens Suppl 2009, 27, S32–S36.
   Google Scholar
• Cerillo A. Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 2008, 31, 181–184.
   Google Scholar
• Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004, 44, 248–252.
   PubMed Web of Science ®Google Scholar
• Dhikav V, Anand K. Potential predictors of hippocampal atrophy in Alzheimer’s disease. Drugs Aging 2011, 28, 1–11.
   PubMed Web of Science ®Google Scholar
• Westhoff TH, Schubert F, Wirth C, Joppke M, Klär AA, Zidek W, Gallinat J. The impact of blood pressure on hippocampal glutamate and mnestic function. J Hum Hypertens 2011, 25, 256–261.
   Google Scholar
• Jenkis TA. Effect of angiotensin-related antihypertensives on brain neurotransmitter levels in rats. Neurosci Lett 2008, 444, 186–189.
   Google Scholar
• Lopez-Real A, Rey P, Soto-Otero R, Mendez-Alvarez E, Labandeira-Garcia JL. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism. J Neurosci Res 2005, 81, 865–873.
   PubMed Web of Science ®Google Scholar
• Hu J, Igarashi A, Kamata M, Nakagawa H. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 2001, 276, 47863–47868.
   PubMed Web of Science ®Google Scholar
• Kumaran D, Udayabanu M, Kumar M, Aneja R, Katyal A. Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats. Neuroscience 2008, 155, 626–639.
   Google Scholar
• Jenkins TA, Chai SY. Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats. Neurobiol Learn Mem 2007, 87, 218–224.
   PubMed Web of Science ®Google Scholar
• Hajjar IM, Keown M, Lewis P, Almor A. Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer’s disease: an observational study. Am J Alzheimers Dis Other Demen 2008, 23, 77–83.
   PubMed Web of Science ®Google Scholar
• Gard PR, Rusted JM. Angiotensin and Alzheimer’s disease: therapeutic prospects. Expert Rev Neurother 2004, 4, 87–96.
   PubMedGoogle Scholar
• Senol N, Ceyhan BM, Ersoy IH, Senol A, Acarturk G, Sutcu R. Aspirin increases NMDA receptor subunit 2A concentrations in rat hippocampus. J Recept Signal Transduct Res 2012, 32, 17–21.
   PubMed Web of Science ®Google Scholar
• Martel MA, Wyllie DJ, Hardingham GE. In developing hippocampal neurons, NR2B-containing N-methyl-D-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 2009, 158, 334–343.
   PubMed Web of Science ®Google Scholar
• Riedel G, Platt B, Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res 2003, 140, 1–47.
   PubMed Web of Science ®Google Scholar
• Newton IG, Forbes ME, Linville MC, Pang H, Tucker EW, Riddle DR, Brunso-Bechtold JK. Effects of aging and caloric restriction on dentate gyrus synapses and glutamate receptor subunits. Neurobiol Aging 2008, 29, 1308–1318.
   Google Scholar
• Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Meth Enzymol 1990, 186, 421–431.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke 2008, 39, 349–354.
   PubMedGoogle Scholar
• Hacioglu G, Agar A, Ozkaya G, Yargicoglu P, Gumuslu S. The effect of different hypertension models on visual evoked potentials. Int J Neurosci 2002, 112, 1321–1335.
   PubMed Web of Science ®Google Scholar
• Westhoff TH, Schubert F, Wirth C, Joppke M, Klär AA, Zidek W, Gallinat J. The impact of blood pressure on hippocampal glutamate and mnestic function. J Hum Hypertens 2011, 25, 256–261.
   Google Scholar
• Dobrek L, Thor P. Glutamate NMDA receptors in pathophysiology and pharmacotherapy of selected nervous system diseases. Postepy Hig Med Dosw (Online) 2011, 65, 338–346.
   PubMedGoogle Scholar
• Shi L, Adams MM, Linville MC, Newton IG, Forbes ME, Long AB, Riddle DR, Brunso-Bechtold JK. Caloric restriction eliminates the aging-related decline in NMDA and AMPA receptor subunits in the rat hippocampus and induces homeostasis. Exp Neurol 2007, 206, 70–79.
   PubMed Web of Science ®Google Scholar
• Knapp LT, Klann E. Role of reactive oxygen species in hippocampal long-term potentiation: contributory or inhibitory? J Neurosci Res 2002, 70, 1–7.
   PubMed Web of Science ®Google Scholar
• Martel MA, Wyllie DJA, Hardingham GE. In developing hippocampal neurons, NR2B-containing N-Methyl-D-Aspartate Receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 2009, 158, 334–343.
   PubMed Web of Science ®Google Scholar
• Koutsilieri E, Riederer P. Excitotoxicity and new antiglutamatergic strategies in Parkinson’s disease and Alzheimer’s disease. Parkinsonism Relat Disord 2007, 13, 329–331.
   PubMed Web of Science ®Google Scholar
• Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 2005, 58, 730–735.
   PubMed Web of Science ®Google Scholar
• Corrêa Mde C, Maldonado P, da Rosa CS, Lunkes G, Lunkes DS, Kaizer RR, Ahmed M, Morsch VM, Pereira ME, Schetinger MR. Oxidative stress and erythrocyte acetylcholinesterase (AChE) in hypertensive and ischemic patients of both acute and chronic stages. Biomed Pharmacother 2008, 62, 317–324.
   Google Scholar
• Markesbery WR. Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 1997, 23, 134–147.
   PubMed Web of Science ®Google Scholar
• Obata T. Imidaprilat, an angiotensin-converting enzyme inhibitor exerts neuroprotective effect via decreasing dopamine efflux and hydroxyl radical generation induced by bisphenol A and MPP+ in rat striatum. Brain Res 2006, 1071, 250–253.
   Google Scholar
• Awad AS. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats. Vascul Pharmacol 2006, 45, 141–147.
   Google Scholar